Pre-induction Analgesia: Multimodel Regimen vs Aceteminophen for Post Ureteroscopy Pain (MMPITR)
Kidney Calculi, Pain, Postoperative
About this trial
This is an interventional treatment trial for Kidney Calculi focused on measuring ureteroscopy, opioids, narcotics, text messaging, real time data acquisition, ecologic momentary assessments, pre-emptive analgesia, gabapentin, meloxicam, tamsulosin, kidney stones, lithotripsy, nephrolithiasis
Eligibility Criteria
Inclusion Criteria:
- Adult Patient (greater than 18 years old)
- Possesses or has access to cell phone with text message capability
- Undergoing ureteroscopy with lithotripsy for a ureteral or kidney stones
Exclusion Criteria:
- Does not possess or have access to a cell phone with text message capability
- Non-English speaking
- Incarcerated individuals
- undergoing planned secondary procedure
- pregnancy
- intellectual disability
- History of, anaphylactic, rash, or other hypersensitivity reaction to any of the study agents
- Patients with history of CABG, myocardial infarction, endovascular cardiac stent, gastrointestinal bleed, or gastric ulcer disease will not receive Celecoxib. They may still participate in the study otherwise, it will be documented that they did not receive an NSAID component.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Multimodel Drug Regimen
Acetaminophen Only
The patients randomized to this arm will receive the following multimodal oral drug regimen administered shortly before induction of general anesthesia Tylenol, 975mg (3 tabs) 800mg Gabapentin 400mg Celecoxib 10mg Oxycodone
The patients randomized to this arm will receive oral acetaminophen only administered shortly before induction of general anesthesia 1. Tylenol, 975mg (3 tabs)